全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

葡萄糖响应苯硼酸接枝壳聚糖盐酸盐抗肿瘤药物载体

DOI: 10.11777/j.issn1000-3304.2015.15004, PP. 1020-1027

Keywords: 苯硼酸,壳聚糖盐酸盐,葡萄糖响应,药物释放

Full-Text   Cite this paper   Add to My Lib

Abstract:

通过分子改性向壳聚糖盐酸盐高分子链中引入苯硼酸基,合成了双亲性化合物苯硼酸接枝壳聚糖盐酸盐.细胞毒性实验表明苯硼酸接枝壳聚糖盐酸盐具有良好的细胞相容性.该双亲性化合物能够自组装成胶束聚集体,并包封疏水药物.以阿霉素为模型药物,研究了载药胶束聚集体的体外药物释放行为,结果表明,阿霉素在载药胶束聚集体内能够持续释放,且具有葡萄糖响应性.在生理pH=7.4和固体肿瘤弱酸性(pH=6.5)条件下,药物的释放速度十分缓慢,而当释放介质中有葡萄糖存在时,药物释放速度都明显加快.

References

[1]  6 M?eller E.Science,1965,147:873~879
[2]  7 Kataoka T,Oh-Hashi F,Sakurai Y.Gan,1982,73:193~205
[3]  8 Gordijo C R,Shuhendler A J,Wu X Y.Adv Funct Mater,2010,20(9):1404~1412
[4]  9 Liu Gan(刘赣),Yang Hao(杨浩),Ma Rujiang(马如江),Shi Linqi(史林启).Acta Polymerica Sinica(高分子学报),2014,(9):1161~1173
[5]  10 Yang Ting(杨挺),Deng Xinxing(邓鑫星),Du Fusheng(杜福胜),Li Zichen(李子臣).Acta Polymerica Sinica(高分子学报),2014,(11):1553~1560
[6]  11 Zhang Y,Guan Y,Zhou S.Biomacromolecules,2006,7(11):3196~3201
[7]  12 Zhao L,Xiao C,Ding J,He P,Tang Z,Pang X,Zhuang X,Chen X.Acta Biomater,2013,9(5):6535~6543
[8]  13 Cambre J N,Roy D,Gondi S R,Sumerlin B S.J Am Chem Soc,2007,129(34):10348~10349
[9]  14 Roy D,Sumerlin B S.ACS Macro Lett,2012,1(5):529~532
[10]  15 Kim K T,Cornelissen J J L M,Nolte R J M,van Hest J C M.Adv Mater,2009,21(27):2787~2791
[11]  16 Kim H,Kang Y J,Kang S,Kim K T.J Am Chem Soc,2012,134(9):4030~4033
[12]  17 De Geest B G,Jonas A M,Demeester J,De Smedt S C.Langmuir,2006,22(11):5070~5074
[13]  18 Du P,Mu B,Wang Y,Liu P.Mater Lett,2012,75:77~79
[14]  19 Shiino D,Murata Y,Kubo A,Kim Y J,Kataoka K,Koyama Y,Kikuchi A,Yokoyama M,Sakurai Y,Okano T.J Controlled Release,1995,37(3):269~276
[15]  20 Matsumoto A,Ikeda S,Harada A,Kataoka K.Biomacromolecules,2003,4(5):1410~1416
[16]  21 Hoare T,Pelton R.Macromolecules,2007,40(3):670~678
[17]  22 Matsumoto A,Yamamoto K,Yoshida R,Kataoka K,Aoyagic T,Miyahara Y.Chem Commun,2010,46:2203~2205
[18]  23 Dowlut M,Hall D G.J Am Chem Soc,2006,128(13):4226~4227
[19]  24 Wang B,Ma R,Liu G,Li Y,Liu X,An Y,Shi L.Langmuir,2009,25(21):12522~12528
[20]  25 Wang B,Ma R,Liu G,Liu X,Gao Y,Shen J,An Y,Shi L.Macromol Rapid Commun,2010,31(18):1628~1634
[21]  26 Ma R,Yang H,Li Z,Liu G,Sun X,Liu X,An Y,Shi L.Biomacromolecules,2012,13(10):3409~3417
[22]  27 Yang H,Sun X,Liu G,Ma R,Li Z,An Y,Shi L.Soft Matter,2013,9:8589~8599
[23]  28 Khor E,Lim L Y.Biomaterials,2003,24:2339~2349
[24]  29 Pavinatto F J,Caseli L,Oliveira O N.Biomacromolecules,2010,11:1897~1908
[25]  30 Kang G D,Song S C.Int J Pharm,2008,349:188~195
[26]  31 Ge Z,Baguenard S,Lim L Y,Wee A,Khor E.Biomaterials,2004,25:1049~1058
[27]  1 Qiu Y,Park K. Adv Drug Deliv Rev,2001,53(3):321~339
[28]  2 Ganapathy V,Thangaraju M,Prasad P D.Pharmacol Therapeut,2009,121(1):29~40
[29]  3 Manna U,Patil S.ACS Appl Mater Interfaces,2010,2(5):1521~1527
[30]  4 Wu Q,Wang L,Yu H,Wang J,Chen Z.Chem Rev,2011,111(12):7855~7875
[31]  5 Phillips J H,Lanier L L.J Immunol,1986,135:1579~1585
[32]  32 Wu Z,Zhang S,Zhang X,Shu S,Chu T,Yu D.J Pharm Sci,2011,100(6):2278~2286
[33]  33 Kurita K.Prog Polym Sci,2001,26(9):1921~1971
[34]  34 Zhu L,Zhao L,Qu X,Yang Z.Langmuir,2012,28(33):11988~11996

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133